News

Stop TB Partnership Craig David Video Series #2

This is the second video in the series: “This is All Worthwhile”

Craig David with South African Schoolchildren

In this clip Craig talks to children about the effects of tuberculosis on young people, particularly the stigma they may face among their peers. He urges them to recognize the symptoms of tuberculosis and ask for help from a parent or teacher if they think they might be infected, reminding them that tuberculosis can be cured.

We see Craig interacting with kids outside the school, kicking around a football in the street, and sitting in the classroom, where he gives a poignant a cappella rendition of his hit “Walking Away”, accompanied by the delighted children beating out a rhythm on their desktops as he sings “I’m walking away… to find a better day”.

Visibly moved, Craig tells the group: “You guys, the fact that you understand it and you are aware makes me feel like this is all worthwhile.”

The video was produced by Fabrica – Benetton’s Research Centre on Communications. Four more videos will be released, one each week, between now and 7 July.

More News
9 Jul 2020
Earlier this week, Johnson & Johnson announced a reduction in the price for bedaquiline in low- and middle-income countries, as part of a collaboration with the Stop TB Partnership's Global Drug Facility (GDF). The immediate change in price will make bedaquiline available through the GDF at the...
18 Jun 2020
On May 21st, Antimicrbial Agents and Chemotherapy published an article on Otsuka's novel anti-tuberculosis compound, OPC-167832. This molecule, a DprE1 inhibitor, demonstrated potent bactericidal activity and exhibited significant combination effects in 2-drug combinations with delamanid,...
17 Jun 2020
On March 25th, Qurient announced the results of their Phase 2 Clinical Trial (ClinicalTrials.gov number, NCT03563599 ), which was a prospective, randomized, open-label trial for proof of concept in humans of their novel anti-tuberculosis drug, Telacebec (Q203). The trial involved 61 newly-diagnosed...